In a statement published on 11 October 2013, the European Medicines Agency declared itself in favour of 3rd and 4th generation pills, emphasising that, in its opinion, the benefits continue to outweigh the risks.
Confirming its first statement published on 11 January 2013, the EMA stated that there was "no reason why a woman taking COC smoothly stops on the basis of this assessment
". It added that, however, "it is significant that women are aware of the risks, signs and symptoms of venous thrombosis and that doctors take into account individual risk factoring when prescribing contraception
". The Agency simply proposed better information on the risks associated with these contraceptive pills, mainly in the package leaflets "to help women make informed decisions because of the choice of contraception with health professionals
It is precisely on the basis of these risks that France decided not to reimburse 3rd and 4th generation pills with effect from 31 March 2013.